Pulmonary Fibrosis: all 685 studies
Page 1 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.
- Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILDNot yet recruitingNCT07859839Phase 4
- Combined Growth Differentiation Factor-15 (GDF-15) and Lung Ultrasound for ILD Screening in Rheumatoid Arthritis and Systemic SclerosisNot yet recruitingNCT07839221
- Diaphragmatic Release vs Inspiratory Muscle Training in Pulmonary FibrosisNot yet recruitingNCT07810153Not applicable
- Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CTRecruitingNCT07761377
- Antifibrotic Therapy Decision-Making in Pulmonary FibrosisNot yet recruitingNCT07722507
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/2
- Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT07679893Phase 2
- Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote MonitoringRecruitingNCT07673237Not applicable
- Safety of Bronchoscopy in Patients With Interstitial Lung DiseaseNot yet recruitingNCT07627594
- Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung DiseasesRecruitingNCT07615504
- Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisRecruitingNCT07572383Phase 2
- This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.Not yet recruitingNCT07570888Phase 4
- Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 TrialRecruitingNCT07482917Not applicable
- Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related DiseasesRecruitingNCT07464132Phase 1/2
- Clinical Application of 68Ga-1A12 PET in Fibrosis-related DiseasesNot yet recruitingNCT07459205
- Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)RecruitingNCT07457463Not applicable
- Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary FibrosisNot yet recruitingNCT07441408Phase 3
- Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)Not yet recruitingNCT07393217
- HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary FibrosisRecruitingNCT07373288
- Western Sweden Systemic Sclerosis ProjectRecruitingNCT07345052
- Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT07284602Phase 3
- Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT07284459Phase 2
- Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control StudyRecruitingNCT07236541
- MOBoxy: MoblO2 to Maintain OxygenationNot yet recruitingNCT07222592Not applicable
- Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation ContextEnrolling by invitationNCT07061873Not applicable
- Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingNCT07019090Phase 2
- Development of FAPI PET as a Non-invasive Biomarker of Pulmonary FibrogenesisRecruitingNCT06940427Phase 2
- Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective StudyNot yet recruitingNCT06922916
- PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.RecruitingNCT06917196
- D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal FibrosisRecruitingNCT06909409
- Telomeres Length in Israeli Fibrotic ILD PatientsEnrolling by invitationNCT06885515
- Implementation of Home Monitoring in Patients With Pulmonary FibrosisRecruitingNCT06883448Not applicable
- USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINICNot yet recruitingNCT06852794Not applicable
- Nucleoside Therapy in Patients With Telomere Biology DisordersRecruitingNCT06817590Phase 1
- Rehabilitation Counselling for Patients with Interstitial Lung DiseaseRecruitingNCT06815185
- Downhill Walking in IPFRecruitingNCT06756230Not applicable
- Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney TransplantationEnrolling by invitationNCT06751602Phase 2
- Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung DiseaseRecruitingNCT06751069Not applicable
- Senicapoc in Patients With Worsening Fibrotic Interstitial Lung DiseaseRecruitingNCT06714123Phase 2
- Precision Diagnosis and Care for Families With Pulmonary Fibrosis in IrelandRecruitingNCT06702228
- Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary FibrosisNot yet recruitingNCT06668051
- P4O2 ILD ExtensionRecruitingNCT06644144
- Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary FibrosisEnrolling by invitationNCT06629623
- Treatable Traits in Interstitial Lung DiseaseRecruitingNCT06626438Not applicable
- Routine vs On-demand ECMO for Lung TransplantationRecruitingNCT06615492Not applicable
- Zinc and Nicotinamide Riboside for Idiopathic Pulmonary FibrosisRecruitingNCT06567717Phase 2
- Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary ExacerbationsRecruitingNCT06546943
- Advanced Imaging for Pulmonary FibrosisRecruitingNCT06532071Phase 2
- Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathRecruitingNCT06528418
- The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung PatientsRecruitingNCT06527612Not applicable
- Clinical Genetics and Screening for Idiopathic Pulmonary FibrosisNot yet recruitingNCT06521125
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy VolunteersRecruitingNCT06482190Phase 1
- Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using DoxycyclineRecruitingNCT06477185Phase 2
- Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.RecruitingNCT06445686
- Magnetic Resonance Lung Function Imaging Study of Pulmonary Fibrosis Combined With Emphysema SyndromeRecruitingNCT06431555
- FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtionNot yet recruitingNCT06416163
- Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic FibrosisRecruitingNCT06413459
- Illness Expectations in Pulmonary FibrosisEnrolling by invitationNCT06327360
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)RecruitingNCT06325696Phase 2
- The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary FibrosisRecruitingNCT06323876
- Telehealth and Onsite Maintenance Exercise in Chronic Lung DiseaseRecruitingNCT06304207Not applicable
- A Retrospective Study of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary FibrosisNot yet recruitingNCT06275295
- Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary FibrosisRecruitingNCT06251687Not applicable
- Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung DiseasesRecruitingNCT06189820Phase 2
- Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary FibrosisRecruitingNCT06162884
- Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation TherapyRecruitingNCT06159660
- SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT06125327Phase 2/3
- Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory DiseaseNot yet recruitingNCT06124859Not applicable
- A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung DiseaseRecruitingNCT06122233Not applicable
- A Clinical Trial on the Treatment of Idiopathic Pulmonary FibrosisNot yet recruitingNCT06102083Phase 2
- Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT06027372
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT05975983Phase 2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy SubjectsRecruitingNCT05912049Phase 1
- Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis PatientsNot yet recruitingNCT05899556
- A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary FibrosisRecruitingNCT05895409
- Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19RecruitingNCT05890573Not applicable
- Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.RecruitingNCT05863091Not applicable
- 99mTc-HFAPI SPECT/CT in Pulmonary FibrosisRecruitingNCT05859763Not applicable
- Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT05755308Not applicable
- Practice of Oxygenation and Respiratory Support During Fiberoptic BronchoscopyRecruitingNCT05681962
- Fibrosing ILD Biomarkers That Rule AccelerationRecruitingNCT05635032
- Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With BronchiectasisRecruitingNCT05604495
- Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung DiseaseAvailableNCT05572996
- Interstitial Lung Disease Research Unit BiobankRecruitingNCT05392881
- Pulmonary Fibrosis Foundation Community RegistryRecruitingNCT05382572
- Optimising Screening for Early Disease Detection in Familial Pulmonary FibrosisRecruitingNCT05367349
- Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary FibrosisAvailableNCT05356052
- Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT05310669
- Immune Modulation by Exosomes in COVID-19RecruitingNCT05191381
- Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CTRecruitingNCT05121779Phase 1
- Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related CoughRecruitingNCT05120934Phase 2
- End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical VentilationRecruitingNCT05098717
- Pirfenidone to Prevent Fibrosis in Ards.RecruitingNCT05075161Phase 3
- Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).RecruitingNCT05052229Early Phase 1
- Effects of Pulmonary Diseases and Their Treatment on Cardiac FunctionRecruitingNCT05042219
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling by invitationNCT04930289
- University of Virginia Natural History StudyEnrolling by invitationNCT04896138
- A Non-pharmacological Cough Control TherapyRecruitingNCT04767074Not applicable
- Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary FibrosisRecruitingNCT04619199Not applicable
- Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary FibrosisRecruitingNCT04541680Phase 3